they cant and should not replace MS therapies
GLP-1 medications are now a hot topic in weight loss and type 2 diabetes care
While the mechanism is not yet proven, there is support for the idea that GLP-1 attenuates the ras homolog gene family, member A (RhoA)/Rho-associated protein kinase (ROCK) signaling pathway, whose activation is known to reduce levels of occludin, claudin-5, and zonula occludens-1 (ZO-1), as well as promote disruption of endothelial tight junctions
Please make sure you call your pharmacy benefit manager (PBM) as they will handle the prior authorization for your prescription and not your medical insurance network
Treatments like Mounjaro and Wegovy have been through rigorous clinical trials and are proven to support weight loss
doi:10.3389/fphar.2021.762654 Rondanelli M, Infantino V, Riva A, et al